download : ? times
File
language
eng
Author
KATO, NOBUO The Institute of Scientific and Industrial Research, Osaka University, Osaka
Description
Although progress has been made in chemotherapeutic strategies against pancreatic cancer, overall survival has not significantly improved over the past decade. Thus, the development of better therapeutic regimens remains a high priority. Pancreatic cancer cell lines were treated with tamoxifen, a novel antitumor fusicoccin derivative (ISIR-042), and anticancer drugs, and their effects on cell growth, signaling and gene expression were determined. Xenografts of Panc-1 cells were treated with tamoxifen, ISIR-042 and 5-fluorouracil (5FU) to determine the effects on tumor growth. The inhibition of the growth of pancreatic cancer cells induced by tamoxifen was effectively reduced by α-tocopherol, a membrane stabilizer. ISIR-042 produced synergistic effects with tamoxifen in inhibiting cell growth. Tamoxifen elevated lipid peroxidation and the release of cytochrome c, and these effects of tamoxifen were reduced by α-tocopherol. ISIR-042 significantly inhibited colony formation and the expression of stemness-related genes of pancreatic cancer cells. The triple combination of tamoxifen, ISIR-042, and 5FU or gemcitabine was effective at inhibiting cell growth and the appearance of drug-resistant cells. This combined treatment significantly inhibited the growth of Panc-1 cells as xenografts without apparent adverse effects. The triple combination of tamoxifen and ISIR-042 with 5FU or gemcitabine may be highly effective against pancreatic cancer by overcoming resistance to therapy.
Subject
tamoxifen
fusicoccin derivative
lipid peroxidation
pancreatic cancer cells
xenograft
Journal Title
INTERNATIONAL JOURNAL OF ONCOLOGY
Volume
47
Start Page
315
End Page
324
ISSN
1019-6439
Published Date
2015
DOI
Publisher
Spandidos Publications
NII Type
Journal Article
Format
PDF
Text Version
出版社版
Gyoseki ID
e29068
e28833
OAI-PMH Set
Faculty of Medicine
このエントリーをはてなブックマークに追加